Wednesday, October 28, 2026
Biotech

Employers Cut Weight Loss Drugs as Costs Soar

Bosses are dropping coverage for popular weight-loss shots, but patients still have ways to get care.

Many workers face a tough surprise during open enrollment. Companies across the country are cutting back on popular weight-loss shots. Monthly bills for these treatments climbed too high for many company budgets.

GLP-1 medications help people lose weight and manage health risks. But paying for them costs businesses thousands of dollars per worker each year. Health insurance premiums spiked across the board as a result. Now, benefit managers are striking the drugs from their list of covered treatments to protect total company budgets.

Patients still have choices ahead of 2027. Drugmakers offer discount cards that reduce cash prices at the pharmacy counter. Some employers now provide digital diet plans and lifestyle coaching instead of expensive prescriptions. Cheaper generic versions and new pills may enter the market soon too.

Check your health plan details carefully before the new year starts. Ask your human resources team about alternative wellness perks. Staying informed helps you protect both your health and your wallet.

Source: CNBC

#Biotech#Healthcare#GLP-1#Weight Loss#Personal Finance

More from Biotech